GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Ending Cash Position

Divi's Laboratories (NSE:DIVISLAB) Ending Cash Position : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Ending Cash Position?

Divi's Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories's annual Ending Cash Position declined from Mar. 2021 (₹20,303 Mil) to Mar. 2022 (₹12,148 Mil) and declined from Mar. 2022 (₹12,148 Mil) to Mar. 2023 (₹1,697 Mil).


Divi's Laboratories Ending Cash Position Historical Data

The historical data trend for Divi's Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Ending Cash Position Chart

Divi's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.00 431.50 20,303.20 12,147.60 1,697.00

Divi's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Divi's Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12147.6+-10450.6
=1,697

Divi's Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0


Divi's Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Divi's Laboratories (NSE:DIVISLAB) Business Description

Traded in Other Exchanges
Address
Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines